No. It depends on the progress of the company and it trial products. The more positive results and news the market receive from GALE the better the out look help equal to higher share prices. Management has to really step up and move the company towards growth and future profits. We need for the products in the pipeline to have very positive effects and pass FDA future approval, so GALE can bring the products to market. Raising operational capital is the first step to keep the company progressing.
Market Data 
Markets 
AI
